Seshadri Neervannan sold $388K of Tarsus Pharmaceuticals, Inc. (TARS) stock

Seshadri Neervannan, Chief Operating Officer of Tarsus Pharmaceuticals, Inc. (TARS), sold 4,564 shares of TARS stock worth $388K, per an SEC Form 4 filed Sep 9, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 4, 2026, 5 days before it was made public.

TARS has moved -15.1% since the trade date, from $90.78 to $77.08 (Sep 22, 2026 close).